Author/Authors :
Kalantari, Mahshad Department of Genetics - Tehran Medical Sciences - Islamic Azad University, Tehran, Iran , Entezari, Maliheh Department of Genetics - Tehran Medical Sciences - Islamic Azad University, Tehran, Iran
Abstract :
Introduction: Glaucium Flavum has recently been studied by researchers and
pharmacists and has been attributed to its antioxidant, antiproliferative
properties. The alkaloid compounds of this plant are also widely used in the
pharmaceutical industry as decongestants and antitussives.
Materials and Methods: In this experiment, first, the cell class (A549) was
cultured in DMEM culture medium containing 10% FBS and then treated with
different concentrations of Glaucium Flavum. MTT assay was performed to
determine IC50 and compare the viability percentage of treated cells with
different concentrations of Glaucium Flavum on days 1, 3, and 5. The qRTPCR
test was used to investigate the effects of Glaucium Flavum with IC50
concentration on the induction of apoptosis, and expression of genes including
P53, Bax, Bad, and Bcl2. Obtained results were analyzed by SPSS software
using ANOVA test.
Results: MTT results showed that Glaucium Flavum causes cell death and
reduces the viability of cancer cells, which was observed in the form of cell
shrinkage, nucleus shrinkage, and chromatin density and determination of 10
μg/ml concentration as IC50 of A549 cells. An increase in the expression of
Bax, P53 and bad apoptotic genes, and a decrease in the expression of the Bcl2
gene also indicate the induction of apoptotic death and the lethal effect of
Glaucium Flavum.
Conclusion: Finally, it can be said that Glaucium Flavum, due to its rich
content of alkaloid and antioxidant compounds, can be a good option to
replace it with chemical drugs in the treatment of lung cancer.